F. Keil et al., Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation, ANN HEMATOL, 78(8), 1999, pp. 376-379
A large group of patients relapsing after allogeneic bone marrow transplant
ation (BMT) have obtained remission after infusion of leukocytes from their
original donor, suggesting a graft-versus-myeloma effect. However, side ef
fects such as graft-versus-host disease and myelosuppression are severe, an
d sometimes fatal, complications of this therapeutic approach. Previously w
e demonstrated that patients with leukemia who lack donor hematopoiesis in
relapse after BMT experience severe and lasting aplasia after infusion of d
onor leukocytes. In two patients - one with extramedullary and one with mar
row relapse after a sex-mismatched transplantation - we analyzed hematopoie
tic chimerism by cell sorting and bone marrow cultures. CD34-positive cells
, CD4-CD8-positive cells, committed progenitors, and LTC-IC were of donor o
rigin, as demonstrated by two-color fluorescence in situ hybridization (FIS
H). Additionally, in relapse complete donor T-cell chimerism was seen. In c
ontrast, plasma cells were of recipient origin in the patient who had a rel
apse in the bone marrow. Both patients were treated with infusions of donor
leukocytes from their original donor. Neither patient suffered myelosuppre
ssion, and one achieved a stable complete remission.